OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
Hung‐Ming Lam, Ryan P. McMullin, Holly M. Nguyen, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 9, pp. 2301-2312
Open Access | Times Cited: 26
Hung‐Ming Lam, Ryan P. McMullin, Holly M. Nguyen, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 9, pp. 2301-2312
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
European Urology (2018) Vol. 74, Iss. 5, pp. 562-572
Open Access | Times Cited: 103
Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
European Urology (2018) Vol. 74, Iss. 5, pp. 562-572
Open Access | Times Cited: 103
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
Yezi Zhu, Susan L. Dalrymple, Ilsa M. Coleman, et al.
Oncogene (2020) Vol. 39, Iss. 45, pp. 6935-6949
Open Access | Times Cited: 84
Yezi Zhu, Susan L. Dalrymple, Ilsa M. Coleman, et al.
Oncogene (2020) Vol. 39, Iss. 45, pp. 6935-6949
Open Access | Times Cited: 84
BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1
Sen Zhu, Dongyu Zhao, Yan Lin, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Sen Zhu, Dongyu Zhao, Yan Lin, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts
Hung‐Ming Lam, Holly M. Nguyen, Mark P. Labrecque, et al.
European Urology (2019) Vol. 77, Iss. 2, pp. 144-155
Open Access | Times Cited: 59
Hung‐Ming Lam, Holly M. Nguyen, Mark P. Labrecque, et al.
European Urology (2019) Vol. 77, Iss. 2, pp. 144-155
Open Access | Times Cited: 59
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer
Elahe A. Mostaghel, Ailin Zhang, Susana A. Hernandez, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 1, pp. 426-439
Open Access | Times Cited: 57
Elahe A. Mostaghel, Ailin Zhang, Susana A. Hernandez, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 1, pp. 426-439
Open Access | Times Cited: 57
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
Xin Li, Lajos Gera, Shumin Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 14, pp. 6873-6890
Open Access | Times Cited: 29
Xin Li, Lajos Gera, Shumin Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 14, pp. 6873-6890
Open Access | Times Cited: 29
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts
Zoi E. Sychev, Abderrahman Day, Hannah E. Bergom, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 5, pp. 452-464
Open Access | Times Cited: 4
Zoi E. Sychev, Abderrahman Day, Hannah E. Bergom, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 5, pp. 452-464
Open Access | Times Cited: 4
Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer
Lesley J. Scott
Drugs (2017) Vol. 77, Iss. 14, pp. 1565-1576
Closed Access | Times Cited: 35
Lesley J. Scott
Drugs (2017) Vol. 77, Iss. 14, pp. 1565-1576
Closed Access | Times Cited: 35
Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
Qiaqia Li, Kilia Y. Liu, Qipeng Liu, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 10, pp. 2023-2033
Open Access | Times Cited: 21
Qiaqia Li, Kilia Y. Liu, Qipeng Liu, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 10, pp. 2023-2033
Open Access | Times Cited: 21
Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling
J.M. Moll, Johannes Hofland, Wilma J. Teubel, et al.
The Prostate (2022) Vol. 82, Iss. 5, pp. 505-516
Open Access | Times Cited: 13
J.M. Moll, Johannes Hofland, Wilma J. Teubel, et al.
The Prostate (2022) Vol. 82, Iss. 5, pp. 505-516
Open Access | Times Cited: 13
BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer
Sen Chen, Changmeng Cai, Adam G. Sowalsky, et al.
Cancer Research (2018) Vol. 78, Iss. 18, pp. 5203-5215
Open Access | Times Cited: 21
Sen Chen, Changmeng Cai, Adam G. Sowalsky, et al.
Cancer Research (2018) Vol. 78, Iss. 18, pp. 5203-5215
Open Access | Times Cited: 21
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
Xiong Zhang, Zenghong Huang, Junjian Wang, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1672-1672
Open Access | Times Cited: 12
Xiong Zhang, Zenghong Huang, Junjian Wang, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1672-1672
Open Access | Times Cited: 12
Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
Verneri Virtanen, Kreetta Paunu, Antti Kukkula, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Verneri Virtanen, Kreetta Paunu, Antti Kukkula, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer
Shipra Shukla, Dan Li, Holly M. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Shipra Shukla, Dan Li, Holly M. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Canonical and Noncanonical Androgen Metabolism and Activity
Karl‐Heinz Storbeck, Elahe A. Mostaghel
Advances in experimental medicine and biology (2019), pp. 239-277
Closed Access | Times Cited: 10
Karl‐Heinz Storbeck, Elahe A. Mostaghel
Advances in experimental medicine and biology (2019), pp. 239-277
Closed Access | Times Cited: 10
The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression
Lin Gao, Bo Han, Xuesen Dong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Lin Gao, Bo Han, Xuesen Dong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer
R. William G. Watson, Haleema Azam, Claudia Aura, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3540-3540
Open Access | Times Cited: 7
R. William G. Watson, Haleema Azam, Claudia Aura, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3540-3540
Open Access | Times Cited: 7
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L. Wright, Martine P. Roudier, et al.
Clinical Genitourinary Cancer (2022) Vol. 21, Iss. 2, pp. 265-272
Closed Access | Times Cited: 3
Dimitrios Makrakis, Jonathan L. Wright, Martine P. Roudier, et al.
Clinical Genitourinary Cancer (2022) Vol. 21, Iss. 2, pp. 265-272
Closed Access | Times Cited: 3
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming
Yatian Yang, Xiong Zhang, Demin Cai, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Open Access
Yatian Yang, Xiong Zhang, Demin Cai, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Open Access
An abiraterone ultraresponsive phenotype
Annette Fenner
Nature Reviews Urology (2017) Vol. 14, Iss. 3, pp. 132-132
Closed Access | Times Cited: 1
Annette Fenner
Nature Reviews Urology (2017) Vol. 14, Iss. 3, pp. 132-132
Closed Access | Times Cited: 1
Supplementary Figures 1 through 7, Supplementary Tables 1 through 7, and Supplementary Materials and Methods from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
(2023)
Open Access
Min Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
(2023)
Open Access
Supplementary Figures 1 through 7, Supplementary Tables 1 through 7, and Supplementary Materials and Methods from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
(2023)
Open Access
Min Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
(2023)
Open Access
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts
Zoi E. Sychev, Abderrahman Day, Hannah E. Bergom, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Zoi E. Sychev, Abderrahman Day, Hannah E. Bergom, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
